BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 30, 2008
View Archived Issues
Recent AstraZeneca patent imparts new HNE inhibitors
Read More
Regression of corneal neovascularization with novel antisense oligonucleotide GS-101
Read More
Vorinostat shows efficacy in glioblastoma multiforme
Read More
Intercell receives further payment as part of strategic alliance with Novartis
Read More
Ipsen starts E.U. filing process for Decapeptyl 6-month formulation
Read More
Ligand to acquire Pharmacopeia
Read More
Merck & Co. and Japan Tobacco enter licensing agreement for JTT-305 for osteoporosis
Read More
Novartis commences "squeeze out" procedure for remaining Speedel shares
Read More
Osiris completes enrollment of stem cell trial in COPD
Read More
Roche acquisition of Arius Research complete
Read More
Summit signs agreement with Orient Pharma to advance SMT-D-001 program
Read More
Takeda submits NDA to the FDA for alogliptin/Actos tablet for type 2 diabetes
Read More
Design, preclinical antiinflammatory activity of AN-2898 detailed
Read More
Recent results show biliverdin to ameliorate ischemic brain injury in rats
Read More
Savient provides business development update for pegloticase
Read More
CHMP recommends marketing authorization for Azarga in open-angle glaucoma
Read More
New antidepressant agents disclosed in recent patents
Read More
Synta reports new immunosuppressant agents in recent patent
Read More
CHMP recommends variations to marketing authorization of Cancidas
Read More
FDA grants approval to Alimta in first-line treatment of nonsquamous NSCLC
Read More
Synvista receives approval to commence phase II SYI-2074 trial in psoriasis
Read More
Takeda submits NDA for alogliptin in Japan
Read More
Takeda submits NDA in Japan for Actos orally disintegrating tablets
Read More
TransMolecular starts dosing in phase I/II radiolabeled TM-601 trial in glioma
Read More
VGX begins follow-on phase I study for antiinflammatory compound VGX-1027
Read More
Antisoma initiates phase II trial of AS-1402 in breast cancer
Read More
Arana Therapeutics files IND for lead antiinflammatory candidate ART-621
Read More
